Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination
2009
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
The measurement and therapeutic implications of circulating tumour cells in breast cancer
2005
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
2002
Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
2000
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
2005
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dissecting the metastatic cascade
2004
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
2007
Cancer micrometastasis and tumour dormancy
2008
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Detection of Breast Cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry
2001
Transcriptional Complementarity in Breast Cancer: Application to Detection of Circulating Tumor Cells
2001
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
To differentiate or not — routes towards metastasis
2012
Cancer Metastasis: Building a Framework
2006 Standout
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Detection and Quantification of Small Numbers of Circulating Tumour Cells in Peripheral Blood Using Laser Scanning Cytometer (LSC®)
2001
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
2014
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Significance, detection and markers of disseminated breast cancer cells
2006
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
Circulating tumour cells in breast cancer
2004
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell—The Unit of Selection
2003
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
2013
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Insight into the heterogeneity of breast cancer through next-generation sequencing
2011
Bone Marrow Micrometastases and Adjuvant Treatment of Breast Cancer
2004
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Apoptosis of circulating tumor cells in prostate cancer patients
2004
Immunity, Inflammation, and Cancer
2010 Standout
Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
2001
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cancer micrometastases
2009
Parallel progression of primary tumours and metastases
2009
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation
2001
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Detection and isolation of prostate cancer cells from peripheral blood and bone marrow
2003
Clonal evolution in cancer
2012 StandoutNature
Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
2005
Systemic Spread Is an Early Step in Breast Cancer
2008
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Novel approaches to target the microenvironment of bone metastasis
2021
Breast cancer metastasis: markers and models
2005 Standout
Detection of carcinoma cells in the blood of breast cancer patients
2000
Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
2000
Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
2005
Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System
2004
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients
2004
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood
2001
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000
Allele-specific copy number analysis of tumors
2010
Clinical Implications of Extracellular HMGA1 in Breast Cancer
2019
IMMUNOMAGNETIC CELL ENRICHMENT DETECTS MORE DISSEMINATED CANCER CELLS THAN IMMUNOCYTOCHEMISTRY IN VITRO
2000
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
2008
A rare-cell detector for cancer
2004
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.
2002
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
2001
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients
2004
Metabolic reprogramming and cancer progression
2020 StandoutScience
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
2006
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy
2001
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology.
2003
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
2004
Works of Elin Borgen being referenced
Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis
2011
Immunomagnetic Techniques for the Enrichment and Detection of Isolated Breast Carcinoma Cells in Bone Marrow and Peripheral Blood
1997
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
1998
A European interlaboratory testing of three well‐known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow
2006
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
2007
Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method
2004
Disseminated tumour cells as a prognostic biomarker in colorectal cancer
2011
Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples
2001
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
2005
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
1999
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
1998
Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
2017
Real-Time PCR Quantification of c-erbB-2 Gene is an Alternative for Fish in the Clinical Management of Breast Carcinoma Patients
2004
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
2003
Increased sensitivity for detection of micrometastases in bone‐marrow/peripheral‐blood stem‐cell products from breast‐cancer patients by negative immunomagnetic separation
1998
Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination
2008
Persistence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse—Results of pooled European data
2006
Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer
2014
The Prognostic Value of Isolated Tumor Cells in Bone Marrow in Breast Cancer Patients
2004
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
2001
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004